default author photo

Francesca Battaglin

University of Southern California - Norris Comprehensive Cancer Center

1441 Eastlake Ave

Los Angeles, CA 90089

United States

SCHOLARLY PAPERS

1

DOWNLOADS

96

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

BMAL1 Links Bevacizumab Resistance in Colorectal Cancer to Circadian Rhythm and Heme Receptor REVERBA

Number of pages: 54 Posted: 07 Apr 2019
Elke Burgermeister, Francesca Battaglin, Fagr Eladly, Wen Wu, Frank Herweck, Nadine Schulte, Johannes Betge, Nicolai Härtel, Jakob N. Kather, Cleo-Aron Weis, Timo Gaiser, Alexander Marx, Christel Weiss, Ralf Hofheinz, Ian S. Miller, Fotios Loupakis, Heinz-Josef Lenz, Annette T. Byrne and Matthias P. Ebert
Heidelberg University - Department of Medicine II, University of Southern California - Norris Comprehensive Cancer Center, Heidelberg University - Department of Medicine II, Heidelberg University - Department of Medicine II, Heidelberg University - Department of Medicine II, Heidelberg University - Department of Medicine II, Heidelberg University - Department of Medicine II, Heidelberg University - Department of Medicine II, RWTH Aachen University - Faculty of Medicine, Heidelberg University - Faculty of Medicine, Heidelberg University - Faculty of Medicine, Heidelberg University - Faculty of Medicine, Heidelberg University - Department of Medical Statistics and Biomathematics, Heidelberg University - Faculty of Medicine, Royal College of Surgeons in Ireland (RCSI), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - IRCCS Veneto Institute of Oncology (IOV-IRCCS), University of Southern California - Norris Comprehensive Cancer Center, Royal College of Surgeons in Ireland (RCSI) and Heidelberg University - Department of Medicine II
Downloads 96 (720,278)

Abstract:

Loading...

BMAL1; REVERBA; circadian rhythm; bevacizumab; colorectal cancer